Patents by Inventor Shau Fong Yen

Shau Fong Yen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190015418
    Abstract: The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers.
    Type: Application
    Filed: September 18, 2018
    Publication date: January 17, 2019
    Inventors: Elisabete Goncalves, Christin Tauchmann, Shau-Fong Yen, Sudha Vippagunta, Zhixin Zong
  • Patent number: 10085993
    Abstract: The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: October 2, 2018
    Assignee: Novartis AG
    Inventors: Elisabete Goncalves, Christin Tauchmann, Shau-Fong Yen, Sudha Vippagunta, Zhixin Zong
  • Publication number: 20170231997
    Abstract: The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers.
    Type: Application
    Filed: July 22, 2015
    Publication date: August 17, 2017
    Applicant: Novartis AG
    Inventors: Elisabete Goncalves, Christin Tauchmann, Shau-Fong Yen, Sudha Vippagunta, Zhixin Zong
  • Publication number: 20120157496
    Abstract: Ophthalmic compositions comprising ketotifen and a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w/v) of hydrogen peroxide, and methods for the treatment and prevention of allergic conjunctivitis using these compositions are provided herein.
    Type: Application
    Filed: February 29, 2012
    Publication date: June 21, 2012
    Inventors: Fu-Pao TSAO, Michelle Wong, Shau-Fong Yen
  • Publication number: 20120015971
    Abstract: This invention relates to topical ophthalmic compositions comprising an ascomycin e.g. for the treatment of inflammatory diseases such as blepharitis.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 19, 2012
    Inventors: Maggy Babiole Saunier, Jean-Claude Bizec, Michelle Pik-han Wong, Shau-fong Yen
  • Publication number: 20110152307
    Abstract: This invention relates to topical ophthalmic compositions comprising an ascomycin e.g. for the treatment of inflammatory diseases such as blepharitis.
    Type: Application
    Filed: March 1, 2011
    Publication date: June 23, 2011
    Inventors: Maggy Babiole Saunier, Jean-Claude Bizec, Michelle Pik-han Wong, Shau-fong Yen
  • Publication number: 20110071186
    Abstract: This invention is directed to ophthalmic compositions comprising an ascomycin for once-a-day administration.
    Type: Application
    Filed: November 30, 2010
    Publication date: March 24, 2011
    Inventors: Michelle Pik-han Wong, Kasey Jon Minick, Shau-fong Yen
  • Publication number: 20110028516
    Abstract: Ophthalmic compositions comprising ketotifen and a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w/v) of hydrogen peroxide, and methods for the treatment and prevention of allergic conjunctivitis using these compositions are provided herein.
    Type: Application
    Filed: October 14, 2010
    Publication date: February 3, 2011
    Inventors: Fu-Pao Tsao, Michelle Wong, Shau-Fong Yen
  • Publication number: 20100113501
    Abstract: This invention relates to topical ophthalmic compositions comprising an ascomycin e.g. for the treatment of inflammatory diseases such as blepharitis.
    Type: Application
    Filed: December 15, 2009
    Publication date: May 6, 2010
    Inventors: Maggy Babiole Saunier, Jean-Claude Bizec, Michelle Pik-han Wong, Shau-fong Yen
  • Publication number: 20080207692
    Abstract: Ophthalmic compositions comprising ketotifen and a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w/v) of hydrogen peroxide, and methods for the treatment and prevention of allergic conjunctivitis using these compositions are provided herein.
    Type: Application
    Filed: April 15, 2008
    Publication date: August 28, 2008
    Inventors: Fu-Pao Tsao, Michelle Wong, Shau-Fong Yen
  • Publication number: 20070048389
    Abstract: Ophthalmic compositions comprising ketotifen and a source of hydrogen peroxide providing an amount of hydrogen peroxide of from about 0.001 to about 0.1% (w/v) of hydrogen peroxide, and methods for the treatment and prevention of allergic conjunctivitis using these compositions are provided herein.
    Type: Application
    Filed: August 26, 2005
    Publication date: March 1, 2007
    Inventors: Fu-Pao Tsao, Michelle Wong, Shau-Fong Yen
  • Publication number: 20050220823
    Abstract: This invention relates to topical ophthalmic compositions comprising an ascomycin e.g. for the treatment of inflammatory diseases such as blepharitis.
    Type: Application
    Filed: March 3, 2003
    Publication date: October 6, 2005
    Inventors: Maggy Saunier, Jean-Claude Bizec, Michelle Wong, Shau-fong Yen
  • Patent number: 6770675
    Abstract: An improved ophthalmic composition, including docosanoid active agents, which is especially useful in lowering intraocular pressure associated with glaucoma. Improvements in IOP reduction efficacy, preservative efficacy and reduced additive concentrations are achieved by utilizing the disclosed compositions which include a docosanoid active agent (e.g., isopropyl unoprostone), in conjunction with selected non-ionic surfactants, preservatives, and non-ionic tonicity adjusting agents.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: August 3, 2004
    Assignee: Novartis AG
    Inventors: Kenneth Warren Reed, Shau Fong Yen, Mary Sou, Regina Flinn Peacock
  • Publication number: 20040102444
    Abstract: The invention relates to methods for the delivery of certain phthalazine derivatives to the retina(s) of a subject in need of treatment.
    Type: Application
    Filed: September 16, 2003
    Publication date: May 27, 2004
    Inventors: Peter Campochiaro, Michelle Wong, Shau-fong Yen
  • Publication number: 20030050255
    Abstract: This invention is directed to ophthalmic compositions comprising an ascomycin for once-a-day administration.
    Type: Application
    Filed: August 23, 2002
    Publication date: March 13, 2003
    Inventors: Michelle Pik-han Wong, Kasey Jon Minick, Shau-fong Yen
  • Publication number: 20030031718
    Abstract: Disclosed are a once-a-day ophthalmic drug composition, comprising in particular ketotifen, comprising a polymer comprising chitosan and a carrier, and a method to treat an ocular allergy comprising administering a once-a-day ophthalmic ketotifen composition comprising chitosan to the eye of a mammal.
    Type: Application
    Filed: June 7, 2002
    Publication date: February 13, 2003
    Inventors: Michelle Wong, Mary Sou, Shau-fong Yen, Kasey Minick
  • Publication number: 20020058049
    Abstract: The present invention provides a stable method for storing a pharmaceutical composition containing a prostaglandin-like-compound. The method has the step of storing the composition in a polypropylene container.
    Type: Application
    Filed: September 14, 2001
    Publication date: May 16, 2002
    Inventors: Michelle Pik-Han Wong, Shau-Fong Yen, Mary Sou, Kasey Jon Minick
  • Publication number: 20020002185
    Abstract: An improved ophthalmic composition, including docosanoid active agents, which is especially useful in lowering intraocular pressure associated with glaucoma. Improvements in IOP reduction efficacy, preservative efficacy and reduced additive concentrations are achieved by utilizing the disclosed compositions which include a docosanoid active agent (e.g., isopropyl unoprostone), in conjunction with selected non-ionic surfactants, preservatives, and non-ionic tonicity adjusting agents.
    Type: Application
    Filed: March 19, 2001
    Publication date: January 3, 2002
    Inventors: Kenneth Warren Reed, Shau Fong Yen, Mary Sou, Regina Flinn Peacock
  • Patent number: 5422116
    Abstract: Disclosed is a sustained release liquid aqueous ophthalmic delivery system and a method of providing a slow and sustained release of ophthalmic treating agents to the eye of a mammal which comprises administering to the eye of a said mammal an effective amount of a homogeneous liquid aqueous ophthalmic pharmaceutical composition, of pH between about 3.0 and about 6.2, which is adminstrable in drop form and which comprises an ophthalmically effective concentration of a said ophthalmic treating agent and about 0.05% to about 10% by weight of the polymer chitosan; said polymer consisting essentially of(A) monomeric .beta.(1.fwdarw.4)-D-glucosamine linked units and of(B) monomeric .beta.(1.fwdarw.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: June 6, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Shau-Fong Yen, Kenneth W. Reed